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Abstract
Background: A significant proportion of children in the social care system in England present with mental health
problems, with the majority experiencing some form of emotional and behavioural difficulties. The most effective
treatments for these children are currently unknown, partly due to a lack of robust, controlled studies. Researchers
have identified a number of obstacles to conducting well-designed research with this population, making the need
to test the feasibility of a randomised controlled trial especially important.
Methods/design: This protocol outlines a two-arm, randomised control feasibility trial to explore the acceptability
and credibility of mentalization-based treatment (MBT) as a treatment for reducing emotional and behavioural
difficulties in looked after children and to test the possibility of addressing a number of methodological challenges
to conducting high-quality research with this population. MBT is a relatively new intervention which, in the
adaptation of the model tested here, includes many of the features of therapy identified in NICE guidelines as
necessary to support children in care. The two arms are MBT and usual clinical care (UCC). The study will take place
in Hertfordshire Partnership University NHS Foundation Trust with follow-up at 12 and 24 weeks.
Discussion: This study will aim to ascertain whether it is worthwhile and feasible to progress to testing the
intervention in a full-scale definitive randomised controlled trial (RCT). This study therefore has the potential to
improve our understanding of the obstacles to conducting high-quality research with this very vulnerable
population, and in the medium term, could help to improve the stability of foster placements and the emotional
well-being of children in care.
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Background
The term “looked after” was introduced in England and
Wales by the Children’s Act, 1989 [1] and refers to chil-
dren who are under 18 and have been provided with
care and accommodation by a local authority’s (LA) chil-
dren’s services. There were 69,540 children looked after
(CLA) in England in March 2015, with the majority
(61%) as a consequence of abuse, neglect and maltreat-
ment [2]. Other reasons children become looked after
include family dysfunction, child disability, parental ill-
ness or disability, and socially unacceptable behaviour.
In a comprehensive survey conducted in 2002 [3], 45%
of CLA aged 5–17 met the criteria for a psychiatric dis-
order, including conduct disorder (37%), and anxiety and
depression (12%), but more recent studies have sug-
gested that the figure could be as high as 72% [4]. This
is in stark contrast to the figure for children with mental
health conditions in the general population, which is es-
timated at 10% [3].
CLA are therefore a vulnerable group with high levels of
need and are at high risk of experiencing mental health
problems [5, 6]. Children in care, when they present to
mental health services, often do so with a complex presen-
tation, including difficulties with emotional regulation and
oppositionality, as well as challenges in forming and main-
taining close social relationships, including with their
carers [7]. Professional support systems are also frequently
identified as lacking a shared understanding of the child’s
needs or for a coherent approach to tackling common
presenting concerns. As the mental health problems that
can arise in these circumstances are significant predictors
of future, long-term maladjustment [8–10], tackling the
emotional and behavioural difficulties of CLA promptly
and effectively is an important priority for health and
social care professionals [11].
A recent analysis of USA data [12] found no difference
in emotional or behavioural problems between CLA re-
ceiving a professional intervention relative to controls
that did not. This analysis, in line with UK experience
[13], provides little evidence that routine care has reli-
able positive effects on the outcomes for this vulnerable
group, with concern that children may be offered a
range of un-manualised and eclectic interventions for
which evidence is lacking regarding their efficacy
(13,14). Although some manualised approaches may be
helpful for particular subgroups of children in care [14],
the lack of a good evidence base for children with mod-
erate emotional and behavioural problems referred to
services means that those children are neither offered
nor do they consistently receive high quality care. The
2013 National Institute of Health and Clinical Excellence
(NICE) guidelines for CLA [11] concluded that “the UK
evidence base does not serve the needs of looked after
children and young people as well as it might” (p.86). It
went on to argue that in most cases this is due to a lack
of well-designed research investigating the effectiveness
of mental health interventions in this population and
drew attention to the “lack of robust, adequately
controlled, studies completed to a high standard” (p.86).
Researchers have identified a number of specific obsta-
cles to conducting high-quality research in a social care
setting with CLA. These include the heterogeneity of
this group of children itself, and the complexity of defin-
ing emotional health and well-being among them [15] ;
the lack of appropriately designed and validated mea-
sures for use with this particular population [15] ; the
lack of training in research methodology among social
work professionals, creating a culture in which “prac-
tice-based wisdom” is valued over clinical trial evalua-
tions [16]; and practical difficulties in accessing
participants and gaining consent for participation of
children in the care system [17].In a recent paper, [18],
the authors report on the struggles they faced in recruit-
ing CLA to a randomised trial, and describe how social
care staff were often unable to prioritise work to recruit
participants over their social care role, and expressed
concerns that randomisation could be unethical or
harmful to this vulnerable population of children.
The current study therefore focuses on the feasibility
of conducting a clinical trial for children in foster care
with emotional and behavioural difficulties, evaluating
the effectiveness of an adaptation of Mentalization Based
Treatment (MBT). MBT is a relatively new approach to
psychological therapy, which grew out of developments
in psychodynamic therapy and attachment research [19].
The approach draws especially on the finding that adults
with early histories of neglect and attachment trauma
often demonstrate a diminished capacity to mentalize,
i.e. to make sense of the actions of oneself and others on
the basis of intentional mental states, such as desires,
feelings, and beliefs [19]. An evidence-base for MBT
with adults with Borderline Personality Disorder has
been developed [20, 21], and more recently studies have
demonstrated the effectiveness of MBT for adolescents
who self-harm [22], as well as for reducing violence in
schools [23]. A range of adaptations of MBT have been
developed for use with children and young people [24],
including a family-based version, MBT-F; [25]. This
approach has been used with a wide range of children
including foster children, with promising results from
one uncontrolled study [26].
The version of MBT tested in this study draws on the
approaches set out above, but with a specific focus on
the needs of CLA and their carers. The focus is on im-
proving the core components of secure attachment, i.e.
an emotional bond between the child and care giver in
which the child has an expectation that their needs can
be met [27], Although MBT has yet to be evaluated
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systematically in work with CLA, the approach has been
manualised, drawing on the evidence-based principles of
MBT for adults with borderline personality disorder, and
includes many of the features set out in the NICE guide-
lines [11] as key elements of the best practice for work
with CLA. Table 1 outlines the features of the MBT ap-
proach that converge with the NICE recommendations.
The objective of this study is to establish whether it is
feasible to conduct a full-scale clinical trial to evaluate
the clinical and cost-effectiveness of MBT for looked
after children who are experiencing emotional difficul-
ties and their carers. This feasibility study will examine
the challenges and establish procedures for a subsequent
large-scale definitive RCT, including the recruitment of a
control group that will receive usual clinical care (UCC).
As a feasibility study, the aims are to test the capacity to
train mental health practitioners to an acceptable level of
treatment integrity; to assess the feasibility of recruitment
processes and study uptake; to establish acceptability and
credibility of MBT as a treatment intervention for CLA; to
establish the feasibility and acceptability to families of con-
ducting a randomised clinical trial; to establish the feasi-
bility of collecting resource-use data, for the purpose of
calculating relative cost-effectiveness; and to constrain a
preliminary estimate of likely treatment efficacy effect size
(treatment outcome measures).
Patient and public involvement
Patient and public involvement (PPI) has included
feedback on the design of the study, instruments and
Fig. 1 Study Flow Chart
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assessments and the development of patient information
and consent materials. They judged that the aims were
relevant, the rationale was persuasive and there were no
design aspects or ethical issues that should be improved
or that they disagreed with. Feedback from service users,
including a focus group with parents and interviews with
children, was also drawn upon in the process of adapting
the MBT model to the treatment of children in foster
care, leading to an increased focus on treatment goals
being set in relation to the needs of young people and
on collaborative working.
Methods/design
Study design
The study is a two-arm, parallel group, single-centre
feasibility randomised trial and will be conducted over a
24-month period.
Setting
The study will be conducted in a child and adolescent
mental health services (CAMHS) targeted service within
a single NHS Trust: Hertfordshire Partnership Univer-
sity NHS Foundation Trust (HPFT). As of August 2014,
there were 1023 children in care in the county. The
CAMHS targeted team is a county-wide service which
works collaboratively with children’s services. It provides
a mental health service to CLA, as well as children and
families who are actively working with social workers in
children’s services.
Participant selection
A total of 42 CLA and their carers will be recruited
from routine referrals to CAMHS targeted team. The
CLA team within HPFT is a cross-county service with
an annual referral rate of 170 children per year. In
2013/14, 74.6% (n = 132) of children referred to the
service would have met inclusion criteria for this
study. Recruitment is planned for 12 months, suggest-
ing that 32% of eligible children will need to be re-
cruited to the study during the recruitment period.
Regular monitoring of study progress will identify po-
tential problems early and allow any corrective action
to be taken.
Inclusion criteria
The inclusion/exclusion criteria listed below were
chosen based upon the eligibility requirements for
children to receive a service from the CAMHS tar-
geted team. The inclusion criteria are primary- and
secondary-school age children (aged 5–16), in foster
care (or kinship care) for a minimum of 4 weeks, re-
ferred to the CAMHS targeted team and accepted as
an appropriate referral following the consultation
meeting with the professional network, with emo-
tional or behavioural problems (based on a score on
the Strengths and Difficulties Questionnaire ≥15,
which is Trust’s own criteria for young people to ac-
cess the CAMHS targeted team).
Exclusion criteria
Participants will be excluded if it is either an emergency/
crisis referral, where an immediate response to a signifi-
cant risk is required, or the referral is specifically for a
psychiatric assessment in specialist CAMHS.
Table 1 The features of the MBT approach that converge with the NICE recommendations
Nice recommendation for looked after children and young people Features of MBT relevant to the
recommendations
Recommendation 6. Support professional collaboration on
complex casework
▪ Promoting professional collaboration
▪ Ensuring that foster carers are included
in the team around the child
Recommendation 7. Ensure everyone involved understands
their role
▪ Promoting professional collaboration
Recommendation 8. Commission mental health services ▪ A focus on early intervention
▪ Promoting well-being and resilience
Recommendation 36. Train foster and residential carers ▪ Supporting social workers to have reflective
conversations with foster carers that include
emotional support and parenting guidance
Recommendation 37. Support foster carers and their families “
Recommendation 38. Train supervisors “
Recommendation 50. Develop a national core training module ▪ Reflective practice for those working with
LAC
Recommendation 51. Train social workers to support looked after children and young people in
education
“
Recommendation 52. Train independent reviewing officers to support looked after children and
young people in education
“
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Procedure
Interventions
All therapy offered by the targeted CAMHS team is up
to 12 sessions. Clinicians employed by the CAMHS
targeted team have varied training, including social
work, clinical psychology, cognitive behavioural therapy,
person centred therapy, supportive counselling, play
therapy and family therapy. Decisions about which ele-
ments of usual clinical care to use for each child are
made on the basis of a “Choice and Partnership
Approach” (CAPA:[13]).
MBT is a short-term manualised treatment equal in
length to UCC (i.e. up to 12 sessions) and delivered by
existing CAMHS clinicians employed by HPFT. The
MBT approach pays particular attention to promoting
mentalizing in the foster carer and developing reflective
practice for all professionals working with the referred
child. The approach includes a combination of psycho-
education about attachment and mentalizing in children
with histories of maltreatment; consultations with the
professional network around the child, when required;
and direct relational work, tailored to the needs of each
foster family, aimed at helping foster families understand
their foster child’s needs and feelings, encouraging sensi-
tive parenting and tackling problematic patterns of foster
family interaction. MBT training of therapists will take
the form of a 4-day group format including a 3-day in-
tensive course, with a further 1-day follow-up session,
provided by a systemic family therapist with expertise in
using MBT with foster carers. Training will end with a
videotaped assessment of performance (see https://
spaces.xememex.com/tiddlymanuals/). Efforts will be
made to keep “contamination” to a minimum by means
of separate, fortnightly supervision arrangements for the
two groups of clinicians. In order to randomly select the
clinicians working in each arm of the study, whilst en-
suring a balance in terms of clinical experience, the six
staff will be paired by the service based on their length
of time in role (experience in months/years), and subse-
quently ordered alphabetically by the study statistician
who will generate a random sequence to randomise the
suggested pairs of therapists into the MBT and UCC
groups. If any member of staff has previous training in
MBT, they will be automatically assigned to the MBT
arm of the study.
Participant identification and recruitment process
The study will build on the existing clinical pathways
for referral to the CAMHS targeted team. As part of
usual clinical practice, all referrals to CAMHS are re-
ceived via the HPFT single point of access (SPA), and
include a written referral, a copy of the Strengths and
Difficulties Questionnaire (SDQ), and confirmation
from the social worker that parent/s or legal guardian
(henceforth referred to as “parents”), where appropri-
ate, have given informed consent to the clinical referral.
Please see Fig. 1 below for a flowchart of partici-
pant progression through the study, from referral to
CAMHS to data analysis.
Consent/assent process
In all cases, recruitment and consent will be the respon-
sibility of the research fellow, clinical studies officer or
trial manager (TM). The nature of the consent that will
be required for the child to be recruited into the study
will be determined by the child’s legal status and their
age. Informed consent to take part in the study must be
received from at least one person holding parental
responsibility for every child under 16 who meets the
inclusion criteria for the study. For children on full or
interim care orders, this will be a representative of the
local authority; for children on voluntary placements,
this will be at least one of the child’s birth parents.
Whilst a child under the age of 16 is not considered to
be competent in law to provide consent, many children
over the age of 12 will be determined as Frazer compe-
tent and will therefore be able to provide consent as to
whether they wish to be considered to take part in the
study. Children will be provided with age-appropriate in-
formation sheets and given reasonable time to consider
the study. Their assent will then be obtained if they are
12 or under, and written consent obtained for 13–16-
year-olds. Where the child is on a full- or interim care
order, a letter and information sheet will additionally be
sent to parents, via their social worker, with details of
the study and confirmation that their child will receive
therapeutic care regardless of whether the child partici-
pates in the study. They will be informed that they may
contact the study team if they have any objections to
their child being part of the research via an “opt-out”
method of consent. This method has been used and rec-
ommended previously [28].
As a feasibility study, data will be collected on how
many participants do not speak sufficiently fluent
English to complete the research measures, but they will
not be excluded from the study. For those participants,
although there may not be validated versions of the mea-
sures available in all languages, participants will be sup-
ported to complete the measures with the aid of an
interpreter.
Randomisation method and blinding
Individual participant randomisation will be utilised for
the duration of the study with children assigned to one
of the two treatment arms (MBT or UCC). Randomisa-
tion will be managed by the Clinical Trials Support Net-
work (CTSN) at the University of Hertfordshire (UH),
and will be requested and actioned electronically by the
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TM via the online secure data management system. Ran-
domisation will be stratified by age (5–11 and 12–16),
sex and whether the participant has siblings who are eli-
gible, and otherwise randomly allocated. Randomisation
will occur as soon as possible after consent has been ob-
tained and the baseline assessment completed.
Six therapists are engaged in the study, and were
placed into three pairs based on experience, ranging
from senior to newly qualified social workers. The thera-
pists were then randomly allocated to a treatment arm
within each pair (one to each arm).
It is not possible to blind the therapists to treatment
allocation, and for pragmatic reasons a decision has
been made not to blind the child and foster family.
Blinding of the child and foster family is judged not to
be desirable (to avoid the perception of manipulation
by the study team), and would be difficult to achieve,
given that the MBT intervention involves active collab-
oration around the use of a mentalizing approach.
The members of the research team collecting and cod-
ing the research data and the study statistician will be
the only team members blinded to treatment allocation;
therefore, randomisation code breaking will not be ne-
cessary during the study.
The outcomes of the study
The key outcomes of the study relate to the feasibility of
conducting a large-scale RCT. The specific feasibility
outcomes are as follows, with details of the instruments,
scales, assessments and interviews to be utilised:
(1)The capacity to train mental health practitioners
(treatment integrity):
The MBT Adherence and Competence Scale [29],
rating both adherence and competence.
Therapist feedback forms, to provide qualitative
feedback about the MBT training and experience
of its use in practice.
(2)The feasibility of the recruitment processes:
A Recruitment Log, including number of children
referred, meeting inclusion/exclusion criteria,
completing baseline assessment, randomised into
the trial and reasons for non-eligibility or non-
participation. This data will help to determine how
long it would take to recruit participants into a de-
finitive trial and the necessary referral levels/num-
ber of services that should be involved.
(3)The acceptability and credibility of MBT as a
treatment intervention for CLA:
A treatment attendance form, recording non-
attendance, and withdrawal with reasons. UCC
group includes details about planned/received
treatment.
The Experience of Service Questionnaire (CHI-
ESQ; [30]) in child, adolescent and carer formats,
assessing service satisfaction.
The Experience of Therapy and the Research
Process Interview [31]; a qualitative interview with
foster carer (and child, where appropriate)
examining the experience and acceptability of the
intervention.
(4)The feasibility and acceptability to families of
conducting a randomised clinical trial:
The Experience of Therapy and the Research Process
Interview [31] includes the family’s experience of,
and barriers to participation in the trial. This
qualitative data, along with data from the Case
Report Form (CRF), will be used to assess feasibility
and acceptability of the trial procedures themselves.
This would include (a) the process of consent and
randomisation and (b) the response rates for
primary and secondary outcome measures,
including retention at each of the three data
collection time points and level(s) of missing data.
(5)The feasibility of collecting resource-use data:
Child and Adolescent Service Use Schedule (CA-
SUS: [32]; assessing resource use.
Child Health Utility 9D (CHU9D: [33]); assessing
health-related quality of life.
(6)To constrain a preliminary estimate of likely
treatment efficacy effect size (treatment outcome
measures), the following treatment outcome measures
will be used to assess the effectiveness of the
intervention in the definitive trial. For the feasibility
RCT, assessment of the treatment outcome measures
will be undertaken to support effect size estimation
and to inform power estimation for the definitive trial.
All the questionnaires will be used for the age ranges
specified below, which indicate the age groups they
are validated for.
Primary treatment outcome measure:
Strengths and Difficulties Questionnaire (SDQ: [34], the
routinely used clinical tool assessing emotional and
behavioural difficulties in children aged 2–17 in the
care system. Primary outcome for child behaviour and
emotional well-being will be the carer-rated SDQ, but
teacher-rated and young-person (11–17 years) rated
versions will also be used, as appropriate.
Secondary treatment outcome measures:
Brief Assessment Checklist (Child and Adolescent
Versions—BAC-C [5–11] and BAC-A (12–16) [35] a
caregiver-reported psychiatric rating scale, for children
and young people, complementing the SDQ.
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Revised Child Anxiety and Depression Scale (RCADS:
Child (8–16) Version and Parent Version: [36], a
measure of anxiety and depression already used as part
of routine outcome monitoring in CAMHS targeted
team in Hertfordshire.
The Parent Stress Index—Short Form (PSI-SF:[37]) used
to assess carer wellbeing and the carer-child
relationship.
The Parenting Efficacy Scale [38], a measure of beliefs
and confidence about parenting skills.
The Parenting Scale [39], assessing parenting practices,
including over-reactivity, a crucial focus of the study.
A Five-Minute Speech Sample (FMSS, [40]), coded using
the Reflective Functioning coding Manual [41] to assess
the caregiver’s capacity for reflective functioning
(mentalizing).
Goal-based Outcome Measure (GBOM: [42]), assessing
service user defined treatment outcomes.
A Significant Events log recording significant life-
events, including placement breakdown, involvement
with youth justice system and school exclusions.
Data collection
Data will be collected at baseline (T1), and then after
12 weeks (T2) and 24 weeks (T3). Table 2 below outlines
the information collected at the different time points.
The visit will take place at a time and place convenient
to the foster carer, either at the foster carer’s home or at
an HPFT site, and is estimated to take up to 2 h.
Table 2 shows the schedule of assessments. During
the baseline assessment, after informed consent has
been obtained, the participants will provide fuller infor-
mation about their demographic status and history as
outlined in the CRF. This basic data set will be followed
by completion of the baseline outcome assessments.
Treatment phase (0–12 weeks)
As part of routine practice, the therapist agrees with the
child and the carer the goal(s) (usually up to three) for
the therapy and goals are reviewed periodically through-
out the therapy sessions. These goals are written down
and recorded on a Goal-Based Outcome Measure
(GBOM) Record Sheet.
Table 2 Schedule of Assessments
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The therapist will complete the Treatment Attendance
Form over the period of therapy (0–12 weeks) for all
participants, for all therapies (MBT and UCC). This
includes details of the type of therapy utilised within the
session (e.g. play therapy, CBT, and MBT). If the partici-
pant did not attend their scheduled therapy session, this
will also be recorded with a reason, where possible.
In order to monitor adherence to the MBT model and
differentiation from UCC, if the participant has con-
sented to sessions being recorded, the therapist will
audio-record each treatment session. At the end of the
study, recordings for two of the families for each clin-
ician in both arms of the study, selected randomly, will
be reviewed by independent raters using an adaption of
the MBT Competence and Adherence Scale to establish
both treatment integrity and treatment differentiation.
Follow up research visits
The T2 visit will occur at 12 weeks post-randomisation,
which may or may not be after therapy has been com-
pleted. At 24 weeks from randomisation (T3), the final
follow-up visit will take place. These assessments will
consist of the outcome assessments completed at the
baseline visit, plus the GBOM Scoring Sheet, the Experi-
ence of Service questionnaire, and record any significant
events that may have occurred in the preceding weeks
since the last assessments. In addition to the T2 mea-
sures, the T3 visit will also include a semi-structured
interview in-person with the carer (and the child, where
appropriate) about their experience of therapy and the
research process. With consent, the interview will be
audio-recorded. The interview will take place after all
other assessment measures have been completed.
Trial governance
The chief investigator (CI) will be accountable to the
sponsor (the Anna Freud National Centre for Children
and Families-AFNCCF) and will hold overall responsibility
for the trial, including submission of required progress re-
ports to the NIHR and NHS ethics committee, deliver-
ables, financial statements and the correct use of funds.
The core study management team will consist of Dr
Nick Midgley, Professor Pasco Fearon and Dr David
Wellsted, who together will take responsibility for
monitoring the overall progress of the study, includ-
ing both data and budget management, and supervis-
ing the RF(s). The TM will manage the day-to-day
running of the study with the support of the Clinical
Trials Support Network.The CTSN will provide data-
management and on-going data monitoring, including
randomisation procedures, setup of the online data-
base and secure management of confidential partici-
pant data. Co-investigators who will provide support
to the study in relation to their specific areas of
expertise. A study steering committee (SSC) has been
set up to monitor progress and advise, meeting five
times (0, 6, 12, 18, and 24 months), and will be re-
sponsible for monitoring patient safety.
Planned analysis
The purpose of the statistical and qualitative analysis is
to evaluate the feasibility of undertaking a full clinical
trial. The strategy employed is therefore to describe as-
pects of the data following the six aims outlined above;
the approach to each aim is described in turn.
Aim 1: evaluation of treatment integrity
The primary data considered will for the first aim be the
MBT Adherence and Competence Scale. The data for
each MBT therapist (N = 3) will be tabulated to deter-
mine whether the therapists are consistently achieving at
least an “adequate” rating on the target therapeutic qual-
ities on the scale. Should any of the therapists not
achieve the target set, the qualitative data will be evalu-
ated to determine the extent to which the reasons could
potentially compromise a training regimen for therapists.
The data for each UCC therapist (N = 3) will be tabu-
lated to determine whether there is a statistically signifi-
cant difference between them and the MBT therapists in
the level of mentalizing techniques used in sessions, i.e.
to establish whether there is differentiation between the
two treatment arms.
Aim 2: feasibility of recruitment
The recruitment data will be presented in terms of abso-
lute numbers and by proportions. In particular, the con-
version of CLA referred to the CAMHS targeted team
into children randomised to the study will be estimated
as a key indicator of the feasibility of undertaking a full
trial. The reasons for being excluded from the study at
each point will be tabulated. The reasons for drop-out
or exclusion will be examined for any consistent trends
that may be addressed in the study design.
Aim 3: acceptability of MBT as an intervention
For this aim, the primary data will be the extent to
which children and carers attended therapeutic sessions
as scheduled and the Experience of Service Question-
naire (CHI-ESQ-[30]). The analysis will tabulate thera-
peutic attendance, using both median and range data,
and seek to determine particular trends where possible.
It may be possible to evaluate the extent to which non-
attendance is related to particular demographic or clin-
ical factors crudely via regression models, or via stratifi-
cation of the sample. Listing and classification of
significant events during the children’s treatment may
also help to highlight different effects on attendance
patterns.
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The acceptability of MBT as an intervention will also
be assessed qualitatively, using the Experience of Therapy
and Research Process Interview. A thematic analysis [43]
will be conducted, to identify which elements of the
intervention were experienced as acceptable or non-
acceptable, and this will inform further development of
the MBT intervention model if a full clinical trial is
undertaken.
Aim 4: feasibility and acceptability of randomisation &
research procedures
The primary aim of this evaluation will be to examine
data completion and retention across the study once the
child has been randomised to a treatment arm. Data
completion rates will be documented across all the out-
come measures, and by treatment arm, and by time
point. The analysis will seek to determine whether data
completion falls below 75%, and potential differences be-
tween treatment arms, responding groups (children,
families, teachers) and by subgroups (sex, age [≤11 or
>11]), or any other demographic or clinical factor.
The study allows for a 30% drop out at the last follow-
up [44]; and the data will be examined similarly for
trends in the drop-out of children and their families.
This will be tabulated according to treatment and sub-
group as outlined above. Drop-out will be matched
(tabulation) to the attendance data and to significant
events to determine the extent to which drop out is de-
termined by these factors. Regression models may be
evaluated whether these factors are potentially inform-
ative and the study sample size allows.
The acceptability of randomisation, as well as other el-
ements of the research design, will also be assessed
qualitatively, using the Experience of Therapy and Re-
search Process Interview. A thematic analysis [43] will be
conducted to identify which elements of the research de-
sign were experienced as acceptable or non-acceptable.
In addition to the process of randomisation, this will in-
clude the assessment burden and the appropriateness of
each of the research measures (e.g. whether the parent-
ing measures were felt to be appropriate for the experi-
ence of foster carers). This will inform the design if a
full clinical trial is undertaken.
Aim 5: resource use data
A similar approach to evaluating (non) completion of
the resource use scales (CAS-US and CHU-9D) will be
applied as for Aim 4. In addition, an evaluation of the
meaningfulness of the data collected on the CA-SUS
compared to the costs incurred by the children involved
in the study will be undertaken. The extent to which the
costs appropriately capture the financial challenge that
the children present to the NHS and Social Care will be
considered.
Aim 6: likely effect size of the intervention
The preliminary effect size estimated for this study is
based on an assumed minimum difference in the SDQ of
2 points given an sd = 7 typical of this sample of children.
This gives a conservative estimate for an effect size of .29,
and the sample size is estimated to enable a lower limit of
0 to be rejected. The analysis will seek to estimate the ef-
fect size from the observed data, with an estimated lower
limit as suggested by Cocks and Torgerson [45].
Evaluating the feasibility of a full scale trial
Principal determinants of whether a full scale trial can
be undertaken will follow evaluation of each of the study
aims as outlined.
Bringing together all the study data will allow trial
feasibility to be considered, including the following:
The potential to train therapists to deliver the
intervention as envisaged and the costs involved.
That the external validity of the study is maximised by
ensuring that drop-out from the study is within accept-
able limits (30%), or that changes can be convincingly
made to the study procedures to allow for improved re-
tention in the study.
That the internal reliability of the study data is
maintained. Data completion for the study measures, and
completion of the therapeutic intervention (attendance)
will be evaluated to ensure that the completion rate is
good (>75%) and that there are no obvious biases in data
completion by any particular subgroup. The qualitative
evaluation will be considered in informing particular
changes that can be made to maximise the study
procedures to improve data completion.
The final report will summarise the data to support
clear decision to proceed to a full trial, and to inform de-
velopment of the study procedures to maximise the
quality of the trial design.
Sample size determination and power
The sample size of 42 is primarily calculated to test
consistency with desired primary outcome effect size.
Following Cocks and Torgerson [45], a sample size suffi-
cient to reject a lower limit for the effect size of 0 is esti-
mated (assuming one sided α = 0.05, 1− β = .80).
Assuming sd = 7 in the SDQ is representative, with a
lower limit = 2 for meaningful clinical change, the effect
size = .29. For a feasibility trial, to reject an effect size of
0 a sample size of 32 (16 in each arm) is required, or 42
children (21 per arm) allowing for 30% drop out.
Discussion
Children who have been taken into the care of the state
are among the most vulnerable members of society, with
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far higher levels of emotional and behavioural difficulties
than the general population, and with poor long-term
physical and mental health outcomes. Yet in their review
of the evidence for effective interventions for this group
[15], the National Institute for Clinical and Health Excel-
lence (NICE) identified few UK-based controlled trials
that were “sufficiently robust or transparent to answer
basic questions such as what interventions work best,
how, for whom, and over what period, and what is good
value for money” [15] (p.82). The lack of data on cost-
effectiveness is a particular obstacle for policy makers
and commissioners, for whom difficult decisions need to
be made about resources and funding.
In the light of these challenges, the present study aims
to test a number of important feasibility questions and
tests a number of methods to try and overcome the bar-
riers that have been identified by previous researchers.
Regarding recruitment, the protocol has been designed
to ensure that social care staff are not relied on to iden-
tify potential research participants, and careful attention
has been paid to ensuring that consent can be obtained
from the relevant parties (including parents, foster
carers, the LA and the children themselves) in a way
that is timely, appropriate and fully informed.
In addition, this study tests the feasibility of collecting
service use data in a way that would help to evaluate the
cost-effectiveness of the intervention as part of a full trial
and combines the use of standardised treatment outcome
measures such as the SDQ, which are already widely used
with CLA, and measures such as the BAC, which have
been specifically designed to assess the emotional well-
being of CLA. Moreover, by combining qualitative and
quantitative data, as recommended by NICE [15] (p.82),
this study aims to identify some of the key barriers to con-
ducting clinical trials with this population, as well as iden-
tify potential ways to address these barriers.
The wide-ranging challenges involved in the present
research mean that a feasibility study is the most useful
design. The overall research question aims to identify
the most cost-effective treatment strategy for these chil-
dren and incorporates a range of measures to identify
the intervention with the greatest potential for positive
impact on emotional health and well-being. By testing
the feasibility of a trial to answer this research question,
our study contributes information of major importance
to the NHS. Potential challenges or difficulties to com-
pleting a larger-scale trial would allow us to modify and
improve our research protocol, or if necessary to not
proceed, if the findings of the feasibility study suggested
that this intervention does not have a significant chance
of improving outcomes for users of the NHS. Our hy-
pothesis is that the outcomes will be better with MBT
than UCC for equivalent cost. Given the current effect
estimate, for roughly every eight families seen, at least
one more family would benefit with MBT than with
UCC, giving a saving to public services of up to £15,382
per family per year (minus the £2000 cost of treatment).
These savings are of course in addition to the benefit of
helping more families with the distress of relational diffi-
culties and emotional and behavioural challenges.
The study could improve the stability of foster place-
ments and the relationships between individuals within
foster families, including a strengthened sense of security
and belonging for CLA. This study therefore has the po-
tential for direct impact on the day-to-day practice of
health service staff, to bring savings to the NHS and
local authorities, education and criminal justice sectors
and benefits for some of the most vulnerable users of
the NHS in England.
Trial status
The current study status is that ethical approval was ob-
tained in December 2015 and the study opened to re-
cruitment in April 2016.
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